Skip to main content

and
  1. Article

    Open Access

    Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril

    Drug therapy often fails to control hypertension. Azilsartan medoxomil (AZL-M) is a newly developed angiotensin II receptor blocker with high efficacy and good tolerability. This double-blind, controlled, rand...

    G Bönner, G L Bakris, D Sica, M A Weber, W B White in Journal of Human Hypertension (2013)